COMMUNIQUÉS West-GlobeNewswire

Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
01/03/2018
MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Versartis, Inc . (NASDAQ: VSAR ), an endocrine-focused biopharmaceutical company, today announced financial results for the fourth quarter and full year ended [...]
Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update
01/03/2018
TYMLOS ™ sales show accelerating market share growth, capturing approximately 32% of osteoporosis patients new to anabolic therapy Abaloparatide patch program advances with FDA alignment on regulatory pathway and [...]
Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2017 Financial Results
01/03/2018
Company Expects to Submit Vitaros End of Review Meeting Request This Month Vitaros End-of-Review Meeting Expected to Occur in April 2018 Company Expects Cash Runway Through 2018 Conference Call / Webcast Today, March 1 [...]
Aduro Biotech Announces Fourth Quarter and Full Year 2017 Financial Results
01/03/2018
BERKELEY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today reported financial results for the year ended December 31, 2017. Net loss for the fourth quarter and year ended December 31 [...]
Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results and Recent Corporate Developments
01/03/2018
-- Fourth quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $57.3 million -- -- Cash and investment balance of $1.1 billion as of December 31, 2017 -- CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- [...]
Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer
01/03/2018
WATERTOWN, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results
01/03/2018
HOLLISTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, [...]
NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs
01/03/2018
AMES, Iowa, March 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported consolidated financial results for the fourth quarter and year ended 2017, as well as progress in its clinical [...]
Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
01/03/2018
BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP ), a biotechnology company focused on development of next generation immunotherapies utilizing gene- and cell-based therapies to treat [...]
MannKind Opens Enrollment of Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension
01/03/2018
WESTLAKE VILLAGE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]
Nkarta Therapeutics Appoints Veteran Executive Paul Hastings as CEO to Lead Next Phase of Growth
01/03/2018
SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing natural killer (NK) immune cells to fight cancer, announced that it has named [...]
UPDATE - FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer
01/03/2018
SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track [...]
Evolent Health CEO Frank Williams Joins Syapse Board of Directors
01/03/2018
SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- Syapse, a leading precision medicine company, announced today that Frank Williams, the co-founder and CEO of Evolent Health, has joined the company’s board of directors [...]
Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018
01/03/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 1 MARCH 2018 at 19.10 EET Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018 In accordance with a decision by the Board of Directors, Orion Corporation has on 1 [...]
CROSSJECT : Financial calendar 2018
01/03/2018
Press release Crossject announces its financial calendar 2018 Dijon, 1st March 2018 CROSSJECT (ISIN: FR0011716265; Ticker: ALCJ), a specialty pharma company developing a portfolio of innovative combined drugs for use in [...]
CROSSJECT : Agenda financier 2018
01/03/2018
Communiqué de Presse Crossject annonce son agenda financier 2018 Dijon, le 28 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de médicaments combinés [...]
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2017 Financial Results
01/03/2018
NEWTOWN, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a [...]
Clover Health Adds Airbnb, Amazon and Google Alums to Executive Team
01/03/2018
SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- Clover Health , a health insurance company using data and technology to fill gaps in care and improve health outcomes, today announced the addition of three new [...]
SuperSonic Imagine Delivers 2,000th Aixplorer® to the First Affiliated Hospital of Sun Yat-sen University in Guangzhou, China
01/03/2018
AIX-EN-PROVENCE, France, March 01, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specialised in medical imaging using ultrasound, announces the installation of its 2,000 th [...]

Pages